Mechanism by which activation of δ-opioid receptor reduces the severity of postresuscitation myocardial dysfunction

Critical Care Medicine

Volumn 34, Issue 10, 2006, Pages 2607-2612

  Fang, Xiangshao ^a,c   Tang, Wanchun ^a,b,c   Sun, Shijie ^a,b   Huang, Lei ^a   Huang, Zitong ^c   Weil, Max Harry ^a,b  

^a INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

opioid receptor; Adenosine triphosphate sensitive potassium channels; Cardiac arrest; Cardiopulmonary resuscitation; Rat

Indexed keywords

ADENOSINE TRIPHOSPHATE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; GLIBENCLAMIDE; PENTAZOCINE; PLACEBO; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CHANNEL GATING; CHRONOTHERAPY; COMPRESSION THERAPY; CONTROLLED STUDY; DEFIBRILLATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; ELECTROCARDIOGRAM; EXPERIMENTAL STUDY; HEART ARREST; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; HEART RIGHT ATRIUM; HEART VENTRICLE FIBRILLATION; INJECTION; LABORATORY; MEASUREMENT; MEDICAL RESEARCH; MOLECULAR DYNAMICS; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; RAT STRAIN; RECEPTOR UPREGULATION; RESUSCITATION; SURVIVAL TIME; TREATMENT OUTCOME;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; CARDIOMYOPATHIES; CARDIOPULMONARY RESUSCITATION; CARDIOTONIC AGENTS; HEART ARREST; MALE; POTASSIUM CHANNELS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SURVIVAL ANALYSIS;

EID: 33748806559     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000228916.81470.E1     Document Type: Article

References (33)

1. Gazmuri RJ, Weil MH, Bisera J, et al: Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 1996; 24:992-1000
2. Tang W, Weil MH, Sun S, et al: Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med 1993; 21:1046-1050
3. Becker LB, Ostrander MP, Barrett J, et al: Outcome of CPR in a large metropolitan area - Where are the survivors? Ann Emerg Med 1991; 20:355-361
4. Brain Resuscitation Clinical Trial I Study Group: Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986; 314:397-403
5. Brown CG, Martin DR, Pepe PE, et al: A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med 1992; 327:1051-1055
6. Liberthson RR, Nagel EL, Hirschman JC, et al: Prehospital ventricular defibrillation. Prognosis and follow-up course. N Engl J Med 1974; 291:317-321
7. Lombardi G, Gallagher J, Gennis P: Outcome of out-of-hospital cardiac arrest in New York City. The Pre-Hospital Arrest Survival Evaluation (PHASE) Study. JAMA 1994; 271:678-683
8. Stiell IG, Hebert PC, Weitzman BN, et al: High-dose epinephrine in adult cardiac arrest. N Engl J Med 1992; 327:1045-1050
9. Tang W, Weil MH, Sun S, et al: Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995; 92):3089-3093
10. Tang W, Weil MH, Sun S, et al: KATP channel activation reduces the severity of postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000; 279:H1609-H1615
11. Sun S, Weil MH, Tang W, et al: Delta-opioid receptor agonist reduces severity of postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 2004; 287:H969-H974
12. Grover GJ: Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 1997; 75:309-315
13. Wang J, Tang W, Sun S, et al: Mechanism by which levosimendan improves outcome of CPR. Abstr. Circulation 2004; 110(17 Suppl):III-531
14. Schultz JE, Rose E, Yao Z, et al: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995; 268:H2157-H2161
15. Schultz JE, Hsu AK, Gross GJ: Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation 1998; 97:1282-1289
16. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78:1100-1104
17. Schultz JE, Hsu AK, Nagase H, et al: TAN-67, a delta1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol 1998; 274:H909-H914
18. Cao Z, Liu L, Van Winkle DM: Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am J Physiol Heart Circ Physiol 2003; 285:H1032-H1039
19. Huh J, Gross GJ, Nagase H, et al: Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 2001; 280:H377-H383
20. Schultz JE, Yao Z, Cavero I, et al: Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol 1997; 272:H2607-H2615
21. + channels in cardiac muscle. Nature 1983; 305:147-148
22. + channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther 1991; 259:961-967
23. Grover GJ, Dzwonczyk S, Parham CS, et al: The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc Drugs Ther 1990; 4:465-474
24. Mizumura T, Nithipatikom K, Gross GJ: Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 1995; 92:1236-1245
25. Rohmann S, Weygandt H, Schelling P, et al: Involvement of ATP-sensitive potassium channels in preconditioning protection. Basic Res Cardiol 1994; 89:563-576
26. Schultz JE, Hsu AK, Gross GJ: Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997; 29:2187-2195
27. Tsuchida A, Miura T, Tanno M, et al: Time window for the contribution of the delta-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart. Cardiovasc Drugs Ther 1998; 12:365-373
28. Miki T, Cohen MV, Downey JM: Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998; 186:3-12
29. Fryer RM, Wang Y, Hsu AK, et al: Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 2001; 280:H1346-H1353
30. + channels. A possible mechanistic link to ischemic preconditioning. Circ Res 1996; 79:399-406
31. Liang BT: Protein kinase C-mediated preconditioning of cardiac myocytes: Role of adenosine receptor and KATP channel. Am J Physiol 1997; 273:H847-H853
32. Gross GJ, Peart JN: KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 2003; 285:H921-H930
33. + channels and myocardial preconditioning. Circ Res 1999; 84:973-979